This JAMA Insights Clinical Update reviews recent evidence favoring use of inhaled corticosteroids (ICS)in all patients with asthma, regardless of frequency, and summarizes the SMART (single maintenance and reliever therapy) treatment approach, which uses an inhaler combining ICS and formotero
|
Scooped by
Gilbert C FAURE
onto Allergy (and clinical immunology) February 12, 2020 4:50 AM
|